| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.23 | 3e-06 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |